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Abstract
Background: While our knowledge of the intestinal microbiota during disease is accumulating, basic information of the
microbiota in healthy subjects is still scarce. The aim of this study was to characterize the intestinal microbiota of healthy
adults and specifically address its temporal stability, core microbiota and relation with intestinal symptoms. We carried out a
longitudinal study by following a set of 15 healthy Finnish subjects for seven weeks and regularly assessed their intestinal
bacteria and archaea with the Human Intestinal Tract (HIT)Chip, a phylogenetic microarray, in conjunction with qPCR
analyses. The health perception and occurrence of intestinal symptoms was recorded by questionnaire at each sampling
point.
Principal Findings: A high overall temporal stability of the microbiota was observed. Five subjects showed transient
microbiota destabilization, which correlated not only with the intake of antibiotics but also with overseas travelling and
temporary illness, expanding the hitherto known factors affecting the intestinal microbiota. We identified significant
correlations between the microbiota and common intestinal symptoms, including abdominal pain and bloating. The most
striking finding was the inverse correlation between Bifidobacteria and abdominal pain: subjects who experienced pain had
over five-fold less Bifidobacteria compared to those without pain. Finally, a novel computational approach was used to
define the common core microbiota, highlighting the role of the analysis depth in finding the phylogenetic core and
estimating its size. The in-depth analysis suggested that we share a substantial number of our intestinal phylotypes but as
they represent highly variable proportions of the total community, many of them often remain undetected.
Conclusions/Significance: A global and high-resolution microbiota analysis was carried out to determine the temporal
stability, the associations with intestinal symptoms, and the individual and common core microbiota in healthy adults. The
findings provide new approaches to define intestinal health and to further characterize the microbial communities
inhabiting the human gut.
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Introduction
Following birth, our gastrointestinal (GI) tract is colonized by a
myriad of microbes, collectively termed the (GI) microbiota, that
develop intimate interactions with our body and contribute to our
health and well-being [1]. Altered GI microbiota has been
detected not only in intestinal aberrations, such as inflammatory
bowel diseases [2] and the milder irritable bowel syndrome (IBS)
[3,4] but also in systemic diseases including type 2 diabetes and
other metabolic diseases [5,6]. Due to the health relevance of the
GI microbiota, the characterization of its diversity and function is
actively ongoing with recently developed molecular high-through-
put technologies, such as next generation technology sequencing of
16S rRNA amplicons and phylogenetic microarrays [7,8].
Several studies have attempted to describe the normal GI
microbiota in healthy individuals but due to the strong individual
variation, low-resolution measurement methodologies and limited
number of samples the task is challenging. Host-specificity and
relative temporal stability of the GI microbiota has been well
established using molecular methods [9–14]. The temporal
stability of the overall microbiota suggests the existence of an
individual core, consisting of microbes that retain within an
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individual over time [7]. The temporal stability may also reflect
the resilience of the ecosystem; even strong perturbations such as
antibiotics have mainly short-term effects on the dominant
microbiota [15–17]. There is evidence for a negative correlation
between the time span and the within-individual microbiota
similarity already in months scale [13,18] possibly reflecting the
cumulative effect of environmental perturbations.
The occurrence of intestinal symptoms and their possible effect
on the quality of life in healthy individuals is largely unknown. In
an American survey, almost half of the general population
reported one or more intestinal symptoms within one month,
the most common complaints being diarrhea or loose stools,
abdominal pain or discomfort, and bloating or distension [19].
The high prevalence of intestinal problems in healthy subjects
suggests their substantial impact on the general well-being.
Accordingly, IBS patients, suffering from various intestinal
symptoms, have significantly impaired quality of life in comparison
to the general population [20,21]. The Health-Related Quality of
Life (HRQoL) can be measured with validated questionnaires that
evaluate the subject’s general, psychological and social well-being
[22]. It is of particular relevance for the emerging interdisciplinary
field of gut health research [23] to find out to which extent the
intestinal symptoms of healthy individuals impair their quality of
life and whether the occurrence of intestinal symptoms is
associated to the GI microbiota composition.
A fundamental question pertaining to the GI microbiota
characterization is the existence of a common core microbiota
that we all may share. The so far presented studies of this common
core GI microbiota are based on the analysis of 16S rRNA gene
sequence inventories [12,14,24–27] or phylogenetic microarray
analysis [13]. Most of the studies indicate only a small
phylogenetic overlap between the individuals. The gene pool of
the GI microbiota, in turn, appears conserved across the
individuals suggesting functional redundancy of the ecosystem
[8,12]. However, the variable abundance between species has so
far been ignored, despite its crucial impact on whether a particular
species is detectable in a given analysis depth and consequently, on
the extent of shared bacteria. The increase in sequencing depth
has been shown to markedly increase the core size as it resulted in
the coverage of those phylotypes that had low abundance in some
of the individuals [8]. It is difficult to the compare the existing
common core studies because of the number of the study subjects
varies, their health status has not been determined and the
required prevalence for the core species has not been defined
[8,12,24]. Moreover, the results are affected by methodological
aspects including the DNA extraction methods [28,29], the choice
of the hypervariable region of the 16S rRNA [12], the coverage of
the selected primers, the analysis depth [8,25], the phylogenetic
assignment and cut off values [30], and the selected bioinformatics
pipeline [31]. As a consequence of the variable study set-ups, there
is currently no consensus about the size and composition of the
common core GI microbiota.
The present study expands the present concept of temporal
dynamics of the overall microbiota and its individual members,
based on frequent sampling and a comprehensive microbiota
analysis with a phylogenetic microarray. Furthermore, we analyze
for the first time, to our knowledge, the associations between the
intestinal microbiota and intestinal symptoms in healthy adults.
We observed that the abundance of several taxa is associated with
intestinal symptoms including abdominal pain and bloating. We
also add a novel perspective to the characterization of the common
core microbiota. We used a sequencing-independent technology
and a novel computational approach, which is not restricted to
prefixed criteria for the phylotype abundance or prevalence but
instead studies how these analytical parameters impact the
resulting core size. Our results highlight the influence of analysis
depth and suggest that when encompassing also the minor
microbiota, a substantial proportion of the intestinal phylotypes
appear to be shared between the individuals.
Results
Definition of the health status
To monitor the subjects’ health, we asked the participants to
record their general, intestinal, and emotional health status at each
fecal sampling point. To focus on the healthy, uncompromised
subjects, and to exclude the potentially confounding samples from
further analyses, we calculated the HRQoL scores and utilized
them in parallel to the background information to categorize the
participants (Table 1). Of the 15 participants, nine subjects
qualified as healthy based on their high general health score that
was comparable to the Finnish reference values [32], high (.90)
GI health score, and the absence of any adverse events during the
study period. The remaining subjects were considered as
compromised: Subject 9 received antibiotic treatment, and
subjects 2 and 4 suffered from considerable intestinal symptoms
(bloating, constipation and abdominal pain) that decreased their
GI health scores significantly compared to those of the healthy
(t-test p-value ,0.05) and negatively affected their general health
perception (Table 1). The remaining three subjects were classified
as compromised based on the combination of exploratory
HITChip data analysis and background information (see next
section).
Comparative analysis of the subjects’ intestinal
microbiota over time
To obtain an overview of the similarity of the total GI
microbiota between all the study subjects, we unsupervisedly
grouped the preprocessed HITChip profiles (see Methods and
Figure S1) using hierarchical clustering with correlation distance
method (Figure 1). The largest differences in the microbiota
profiles were the inter-individual differences (mean inter-individual
Pearson correlation; r = 0.78, standard deviation; 60.04). All
samples clustered in a subject-wise manner (Figure 1), and a high
overall stability of the individuals’ microbiota was observed (mean
intra-individual r = 0.96, 60.02 over all time points).
Despite the overall stability we detected substantial variation in
the temporal dynamics of the subjects’ microbiota as visualized by
the variable lengths of the branches in the clustering tree. Subject
9 was on an antibiotic course during the collection of the fourth
sample, which separated clearly from the other samples (Figure 1).
Also the preceding sample taken two weeks earlier branched
deeply in the dendrogram implying a distinct microbiota profile.
At that time the subject was not medicated but was ill and few days
later diagnosed with streptococcal pharyngitis. Apart from the
antibiotic treatment, we observed no correlations between the
microbiota composition or stability and the recorded medication
(subjects 1,3,7 and 11 received regularly thyroid or estrogen
hormones, or hypertension treatment). A decreased temporal
stability was also observed in subjects 5, 6, 8 and 11 (Figure 1). For
all these subjects, with the exception of subject 5, the decreased
stability could be explained in the light of the background
information. Subjects 6, 8 and 11 had records of travelling during
the first weeks of the trial, passing different time zones in a range of
1–7 hours. The similarity between the samples taken before and
after the travelling was statistically significantly lower than
between the samples taken two to four weeks after travelling
(r = 0.90, 60.02 and 0.96, 60.02, respectively; t-test p-value
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,0.05) (Figure S2). Accordingly, the travelers showed significantly
lower intra-individual stability of the GI microbiota than the nine
healthy subjects (r = 0.9360.01 and 0.96, 60.02, respectively;
t-test p-value ,0.05), suggesting that the GI microbiota was
affected by the travel. Therefore, although the travelers were
healthy, we classified them in this context as compromised
together with the three subjects affected by an antibiotic treatment
or persistent intestinal symptoms (Table 1). The rationale for such
classification was to focus the compositional microbiota analysis on
those healthy subjects for which we did not observe any traceable
destabilizers.
Compositional microbiota analysis
The GI microbiota in the nine healthy uncompromised subjects
was analyzed in detail using HITChip signal intensities of species-
like taxa that we hereafter term phylotypes (level 3 phylogeny in
Methods and [13]). We detected on average 470 phylotypes per
subject, representing 68.4% of the total number of the phylotypes
that passed the signal treshold (Figure S1). The most abundant
phylum in the study subjects consisted of Firmicutes with over
80% contribution to the total microbiota, followed by an average
10% of Bacteroidetes and 1.5% of Actinobacteria (Figure 2).
Verrucomicrobia and Proteobacteria were detected with propor-
tional share below 1% (data not shown). As expected, the most
abundant Firmicutes were the members of Clostridium clusters
XIVa and Clostridium cluster IV, comprising of an average
proportion of 40% and 35% of the total microbiota, respectively.
Based on Methanobrevibacter–specific quantitative PCR (qPCR),
intestinal methanogens were present in 80% of the individuals
(12/15). In one subject (subject 2; Figure 2) the methanogens were
detected only in a single timepoint, while other 11 carriers had
them in all the timepoints. The abundance of the methanogens
varied over two orders of magnitude between the carriers, ranging
from log10 counts of 7.1 to 10.2 g-1 feces. The relative proportion
of the methanogenic archaea in the total GI microbiota was
determined by the ratio of the 16S rRNA gene copy numbers of
the methanogens and the total bacteria. The proportion of the
methanogens was below 1% in most of the samples while in
subject 14 the methanogens represented 1–5% of the total
community across the timepoints.
Temporal variation of the healthy microbiota and the
individual core
We analyzed the effect of time on the microbiota variation in
the nine healthy subjects by determining the similarity of the
HITChip profiles between the intra-individual samples. The
similarities were determined by a correlation coefficient computed
for all possible time intervals from one to seven weeks. The mean
intra-individual Pearson correlations ranged from 0.96 (60.02;
one week interval) to 0.95, (60.02; seven week interval), showing
only a slight, non-significant, decline in the microbiota similarity
over time. In order to address the individual core consisting of
microbes that retain over time, we determined the taxon-specific
temporal variability by calculating the Coefficient of Variation
(CoV) within a subject for each phylotype. The CoVs ranged from
0.83% (uncultured Ruminococcus callidus-like bacterium) to 46.1%
(phylotype within uncultured Clostridiales) with an average of
6.3% (61.1%), reinforcing the high overall stability. Among the 50
most stable genus-level taxa per subject, the most common
statistically enriched genus-level groups were Ruminococcus obeum
and relatives (et rel.), affiliated to the recently renamed genus Blautia
[33] with an average CoV of 3.7%, and Clostridium symbiosum et rel.
with an average CoV of 4.4% (Table S1). No other stable genus-
level taxon was shared by.50% of the healthy subjects, indicating
subject-specificity of the stable species, i.e. of the individual core
microbiota. Similarly, we determined the 50 statistically signifi-
cant, temporally most unstable phylotypes per each healthy subject
(Table S2). The most common unstable genus-like taxa were
uncultured Clostridiales and Bacteroides vulgatus et rel. (CoV 9.9%),
but even they were common to only few individuals. Not only the
commonness but also the actual CoVs of the unstable groups had
larger inter-individual variation than the stable ones, indicating
Table 1. Demographic table, assigned health status (see text for details) and the HRQoL scores of the study subjects.
Subject ID Gender Age (SD) BMI (SD)
Assigned health status
Healthy (H) or Compromised (C)
General health
score* (SD)
GI symptom
score* (SD)
Mental health
score* (SD)
1 m 54 26.8 H 75 (0) 100.0 (0.0) 80.8 (0.0)
2 f 53 20.3 C (GI symptoms) 66.7 (5.3) 68 (21.8) 58.6 (7.4)
3 f 51 31.7 H 58.3 (5.3) 95.7 (3.3) 76.3 (5.1)
4 m 44 20.7 C (GI symptoms) 47.2 (28.7) 63.3 (27.2) 52.6 (20.2)
5 f 42 21.5 H 79.2 (4.6) 98.3 (2.0) 93.9 (5.3)
6 f 56 29.1 C (Traveler) 73.6 (6.3) 99.8 (0.6) 75.0 (3.2)
7 f 30 17.6 H 70.8 (14.7) 92.9 (4.0) 76.9 (4.4)
8 m 30 23 C (Traveler) 79.2 (11.5) 96.1 (2.9) 80.8 (5.0)
9 f 40 23.6 C (Antibiotics) 55.6 (22.8) 94.1 (1.3) 65.4 (8.9)
10 f 27 20.8 H 79.2 (14.7) 92.9 (3.7) 85.6 (2.7)
11 f 54 26.1 C (Traveler) 68.1 (16.2) 90.7 (3.2) 64.7 (10.5)
12 m 51 25.9 H 68.1 (8.2) 96.6 (1.2) 69.2 (13.5)
13 m 47 24 H 65.3 (3.4) 96.1 (0.8) 78.5 (1.4)
14 f 45 21.7 H 83.3 (5.3) 98.8 (1.1) 85.9 (4.0)
15 f 39 21.3 H 68.1 (3.4) 99.0 (1.8) 80.4 (3.3)
Average 5 m/10 f 44.2 (9.5) 23.6 (3.3) H 69.2 (9.9) 92.1 (11.1) 75.0 (11.0)
*The health scores represent average from the six time points.
doi:10.1371/journal.pone.0023035.t001
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that no genus-level group was generically unstable. Few genus-like
groups, including F. prausnitzii et rel., were in the top list of both
stable and unstable taxa (Tables S1 and S2), highlighting the large
individual variation in the temporal behavior of these taxa. In
contrast, the methanogenic archaea appeared temporally very
stabile among the carriers, as the intra-individual CoVs calculated
from the qPCR data were limited to a range of 1% to 6%.
Correlation between intestinal symptoms and the GI
microbiota
Despite the good general health of the participants, only one out
of the 15 subjects did not experience any intestinal complaints
during the study period (subject 1; Table 1). However, occasional
and mild intestinal problems dominated the answers as only two
subjects had intestinal health score below 90 out of 100 (Table 1).
To detect the bacteria associated to specific intestinal symptoms,
we correlated the HRQoL–questionnaire scores and the micro-
biota using the HITChip data from all the 15 subjects. We could
identify 170 phylotypes, which correlated statistically significantly
(q,0.005) with 14 HRQoL-questions related to intestinal
symptoms (Figure 3). The significant correlations were most
frequently found for general intestinal discomfort, urgent need for
defecation, postprandial fullness, and abdominal pain. About half
(53%) of the 170 phylotypes correlated negatively with the
symptoms, showing higher abundance in the absence of the
symptoms. The negatively correlating genus-like taxa included
Bifidobacteria, R. obeum et rel., Streptococcus bovis et rel., Clostridium
difficile et rel. (mostly due to the nonpathogenic Clostridium irregularis)
and Ruminococci. The other half showed a positive correlation
with the observed symptoms so that the probe intensities were
higher when the symptoms occurred. The positively correlating
phylotypes represented mainly members of the Clostridium
clusters IV and XIVa, among which uncultured members of
the F. prausnitzii et rel. and C. symbiosum et rel. were the most
predominant groups.
We next aimed to identify the bacteria related to the symptoms
that were most frequently experienced in our survey, namely
bloating (31 complaints from 8 subjects) and abdominal pain (28
complaints from 8 subjects). For bloating, the severity of the
recorded complaints varied from strong discomfort (2 records) to
mild symptoms (23 records). Several uncultured phylotypes from
Clostridium clusters IV and XIVa had statistically significant
positive correlation with bloating (Table S3). The abundance of
phylotypes within Anaerotruncus colihominis et rel., Ruminococcus callidus
and Lachnospira pectinoschiza et rel. were over ten-fold higher when
bloating was recorded.
The subjects experienced abdominal pain in varying degree so
that the severity of the recorded complaints ranged from very
strong disturbance (1 record) to mild symptoms (20 records). The
most striking finding related to the abdominal pain was its negative
correlation with the abundance of Bifidobacteria (r =20.45,
60.03; Table S4 and Figure 3). The majority of the Bifidobacterium
phylotypes that were above the detection limit (14/21) had
statistically significant (q#0.02) negative correlation with abdom-
inal pain. The subjects who experienced pain had over five-fold
Figure 1. Hierarchical clustering of the HITChip profiles of 15
subjects and their six timepoints. The subject-wise clustering is
highlighted with boxes and the temporal variation is displayed with the
variable length of the branches. Red vertical line is drawn at Pearson
correlation of 0.925, below which the intra-individual sample similarity
was detected only in the five unstable subjects (5,6,8,9 and 11)
discussed in the text.
doi:10.1371/journal.pone.0023035.g001
Core Microbiota and Digestive Symptoms in Adults
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e23035
(on average 5.4, 61.3) less Bifidobacteria compared to the subjects
without recorded pain (Figure 4A). Moreover, a genus-specific
qPCR, covering most cultured members of this group, revealed a
statistically significant difference and a fold change of two
(Wilcoxon test p,0.05) in the Bifidobacterial counts according
to the symptom status (Figure 4B).
In addition to Bifidobacteria, one phylotype within R. lactaris et
rel., Clostridium cluster IV, was significantly decreased in pain-
associated samples (Table S4). Among the positive correlations,
uncultured, potentially pathogenic phylotypes within Uncultured
Clostridiales II, Anaerotruncus colihominis et rel. and R. callidus, were
increased over ten-fold when pain was recorded (Table S4). C.
symbiosum and uncultured phylotypes affiliated to F. prausnitzii et rel.
were more abundant in subjects experiencing postprandial fullness
(Figure 3). The positive correlation between postprandial fullness
and the abundance of F. prausnitzii was confirmed with qPCR (data
not shown). The symptom scores of bloating and abdominal pain
correlated strongly (r=0.72). Four genus-level Clostridial groups
were significantly correlated with the both symptoms, albeit in a
non-uniform direction (Tables S3 and S4).
The common core microbiota
In-depth phylogenetic microarray analysis provided the oppor-
tunity to explore the common core microbiota that is potentially
shared between the healthy individuals. Most of the present efforts
in determining and defining the microbial core have focused on
the presence and absence of phylotypes in a defined proportion of
the study subjects. Instead of using arbitrary criteria for the
abundance and prevalence of the phylotypes, we addressed the
common core microbiota using a novel approach that exploits
adjustable values of these two parameters. Considering the relative
abundance, we utilized the full dynamic range of the HITChip
microarray and incorporated the phylotypes that at lowest
comprised as little as 0.02% of the estimated total signal while
the most dominant phylotypes had over 5% relative abundance.
With regard to the prevalence, we accommodated all possibilities
between 0–100% (n= 0–9). The averaged HITChip data from the
six timepoints per person were used. As a result, the size of the
common core is not a single number but instead a continuum from
zero to hundreds, depending on the selected abundance and
prevalence values as visualized with a perspective plot (Figure 5A).
At the prevalence of 50%, only 10 phylotypes remained in the
common core when the minimum abundance was set as high as
0.5% of the estimated total signal. On the other hand, when all the
phylotypes above the detection limit were accepted, changing the
prevalence from 50% to 100% had much less effect in the number
of the core phylotypes. In other words, the number of the shared
phylotypes decreased dramatically when a phylotype was required
to be in high abundance in all samples, emphasizing the
contribution of the low-abundance bacteria in the core.
By including all the phylotypes above the signal treshold in all
the nine healthy subjects, we detected 288 phylotypes in the
common core (Figure 5B and Table S5). The 288 phylotypes
represented 41.9% of all the detected phylotypes, indicating a high
degree of phylogenetic overlap between the individuals. The exact
taxon numbers should be regarded with caution as they are subject
to noise arising e.g. from unintended cross-hybridization with non-
target sequences and differences in the probe binding affinities. To
estimate such noise, and to exclude the possibility that related
probe-level effects would have remarkably affected the common
core composition and size, we used the Robust Probabilistic
Averaging algorithm designed for probe performance analysis
[34]. For the vast majority of the common core phylotypes (234;
81%) the correlation between the probabilistic and the standard
method was .0.9, indicating a low proportion of potentially false
positives among the detected core phylotypes. The preprocessing
did not affect the phylogenetic composition of the core as the 22
phylotypes detected with most unreliable probes (r,0.8) were all
assigned to the diverse and polyphylogenic Clostridium clusters
XIVa and IV that vastly dominated the core with 145 and 111
Figure 2. Microbiota composition of the study subjects. Relative abundance of the phylotypes that contributed over 0.5% to the total HITChip
signal was summed up to phylum level, except Firmicutes, which were summed up to class or Clostridium cluster level (left y-axis). The qPCR-based
quantification of the methanogens is shown on the right y-axis.
doi:10.1371/journal.pone.0023035.g002
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phylotypes, respectively (Table S5). The majority of the core
organisms were uncultured phylotypes, belonging to 43 different
genus-like taxa from five phyla (Figures 5B and 5C). The most
represented groups were R. obeum et rel. (37 phylotypes), F.
prausntizii et rel. (25 phylotypes) and O. guillermondii et rel. (20
phylotypes). Bacteroidetes, Actinobacteria, Proteobacteria and
Verrucomicrobia were also represented in the core (Figure 5
and Table S5), in line with their established inhabitance in the
human gut. Most of the core phylotypes had a highly variable
abundance among the healthy individuals (Figure 5C).
Temporal stability of the common core bacteria
In addition to studying the temporal dynamics of the total
microbiota, we defined the temporal variation of the common core
phylotypes determined above. We found that the intra-individual
CoV of the core phylotypes ranged from 3.3% to 23% indicating
higher stability of the core phylotypes compared to all detected
phylotypes that were discussed above. The vast majority (70%) of
the core phylotypes fluctuated less than 10% during the study
(Figure S3). The stable core phylotypes were predominantly
members of the Clostridium cluster XIVa but also few taxa
belonged to Clostridium cluster IV. The most predominant stable
genus-level group included R. obeum et rel. and C. symbiosum et rel.
whose stability was apparent also in the examination based on
CoV analysis of the entire microbiota (Table S1).
We also studied the potential correlations between the
abundance and the temporal stability (CoV) of the genus-like
taxa. The only group showing strong correlation between the
abundance and temporal stability was F. prauznitzii et rel.
(r=20.66; Figure S4). The negative correlation between the
abundance and stability indicated that F. prauznitzii was temporally
stable only when it was a very abundant member of the
microbiota, in contrast to other common gut inhabitants such as
Bifidobacteria, which fluctuated in time independently of the
abundance (r=20.12; Figure S4). We verified the finding of F.
prauznitzii with a species-specific qPCR assay, which also indicated
strong negative correlation between its abundance and temporal
stability (r=20.56).
Discussion
This study provides the phylogenetic analysis of the intestinal
microbiota of subjects with verified intestinal and general health
status. The subjects were followed regularly over two months. We
utilized a phylogenetic microarray, capable of detection and
relative quantification of over thousand intestinal phylotypes [13].
In combination with the health status analysis this allowed us to: 1.
Address the composition and temporal dynamics of the GI
microbiota, 2. Relate specific microbial groups to the intestinal
health status, and 3. Provide new insight into the existence and
dimensions of the common core microbiota that we all share.
It has been well established that the human GI microbiota is
dominated by Firmicutes and Bacteroidetes followed by Actino-
bacteria and Verrucomicrobia [8,12,35]. The same phyla
dominated the GI communities in our study subjects (Results
and Figure 2). We detected almost 500 bacterial phylotypes per
individual and methanogenic archaea in 80% of the subjects,
indicating that our data set should adequately describe the
sampled fecal communities based on the current richness estimates
[16,24]. The methanogenic archaea were detected in high
prevalence and at variable inter-individual but consistent intra-
individual abundance. In contrast to the previous findings [36],
our results suggest that the methanogenic archaea are temporally
stable members of the GI microbiota and hence may constitute
Figure 3. Correlation heatmap of the microbiota profiles and intestinal symptoms. The heatmap visualizes all significant (q-value ,0.005)
Spearman correlations between the intestinal symptoms and the HITChip-measured abundance of bacterial phylotypes. Each row represents a single
phylotype, whose genus-level assignments are listed below the rows, or in the middle when several rows refer to the same genus-level group. The
negative correlations between symptoms are indicated in red and the positive correlations with yellow; non-significant correlations are shown in
gray.
doi:10.1371/journal.pone.0023035.g003
Figure 4. Quantification of Bidifobacteria in relation to abdominal pain. The samples were divided into two groups: with and without
concurrent abdominal pain, and the abundance of Bifidobacteria in each group was determined using A. HITChip and B. qPCR. The difference
between the groups was statistically significant (q#0.02 in A; p,0.05 in B). The box extends from 25th percentile to 75th percentile, with a line at the
median; the whiskers extent to the highest and lowest values.
doi:10.1371/journal.pone.0023035.g004
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part of the individual core in the carriers. One possible
explanation for the mentioned differences is the use of efficient
DNA extraction method in this study, resulting into improved
detection of the archaea [29].
Our extensive short-term follow-up confirms the low temporal
variation of the overall GI microbiota in healthy subjects [10,11].
High temporal stability suggests a strong selection by the healthy
host for the particular assemblage of microbes, additionally
Figure 5. Definition of the common core microbiota. A. Perspective plot is used to visualize how the number of phylotypes in the common
core is a function of the selected abundance and prevalence. Light gray indicates the area where no phylotypes passed the given criteria. B. The
common core microbiota in the healthy subjects. The y-axis represents the range of the phylotype count shared, thus forming the common
core, in the nine healthy subjects. The line visualizes how the number of the phylotypes depends on the selected percentile abundance, and how it
decreases drastically when the phylotypes with lowest abundance are excluded. List shows phylum-level summary of the phylotypes that contributed
with over 0.03% relative abundance C. The common core phylotypes summarized to genus-level taxa. The boxplots visualize the intra-
individual variation in the abundances of the core taxa. Bacteroides fragilis et rel. and Bifidobacteria (two leftmost boxes) are visualized for reference
purposes. These taxa were not part of the common core due to their large intra- and inter-individual variation. For boxplot details, please see the
legend for Figure 4.
doi:10.1371/journal.pone.0023035.g005
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supported by the fact that the stable taxa differed across the
individuals and hence there was little phylogenetic commonality
between the individual cores. However, the stable genus-level taxa
may constitute a functionally uniform group as most of them
belonged to order Clostridiales, many of which are ubiquitous
hydrolytic or fermentative carbohydrate utilizers.
The cluster analysis showed subject-specificity in the bacterial
profiles despite the alterations that transiently decreased intra-
individual microbiota similarity in few study subjects (Figure 1).
Antibiotic treatment is a well-documented modifier of the GI
ecosystem [15,16]. In addition, also the microbial profile collected
during non-medicated streptococcal pharyngitis separated clearly
from the baseline samples of the affected subject. This finding
suggests that infection per se may transiently modulate the GI
microbiota, supporting a previous, analogous observation associ-
ated to fever [37]. As a novel observation, we found that travelling
correlated with altered GI microbiota as the similarity of the
microbiota profiles decreased significantly following overseas
travelling. Various factors could cause the travel-related microbi-
ota instability, including exposure to new environmental microbes,
stress or disturbances of the circadian rhythms. Our results in the
studied small cohort indicate that normal life changes, such as
illness, medication and travelling affect the microbiota homeostasis
in a seemingly temporary manner that does not challenge the
individuality of the microbiota.
Our results imply that the overall microbiota stability and
intestinal symptoms may not be associated to each other. The
microbiota profiles of the subjects who reported the most severe
intestinal symptoms (Table 1) remained highly stable during the
study (Figure 1). Additionally, the instability of the microbiota did
not manifest as intestinal symptoms according to the health score
records (Table 1), in line with previous studies suggesting that
healthy subjects may have an unstable microbiota in the absence
of any intestinal complaints [16,38]. As this study did not involve
food diaries, we could not estimate the extent and nature of dietary
influences on the temporal stability and the occurrence of the
intestinal symptoms. Hence, future studies with dietary records
and larger cohorts are needed to verify the findings.
While the occurrence of the intestinal symptoms was not
reflected on the stability of the GI microbiota, we identified
bacteria whose abundance was statistically significantly associat-
ed to the symptoms. The most striking finding at the genus-level
was the decreased amount of Bifidobacteria coupled to
abdominal pain (Figure 4). Thought the majority of the pain
scores indicated only minor disturbance, the reduction in the
Bifidobacterial abundance was evident. This study is the first, to
our knowledge, to study the correlations between the microbiota
composition and intestinal symptoms in healthy individuals,
while two studies have analyzed the associations between the IBS
patients’ GI symptoms and the intestinal bacteria using qPCR
[39,40]. A weak negative association between bifidobacterial
counts and the symptoms was described [39,40] while another
study did not find such association [40]. Several studies have
reported decreased levels of Bifidobacteria in IBS patients
(reviewed in [41]) and a probiotic B. infantis is documented to
reduce visceral pain both in IBS patients [42] and animal model
[43]. The mechanistic background for the ability of Bifidobac-
teria to eliminate pain is not known but can be speculated in the
light of the multiple metabolic traits of Bifidobacteria that impact
the host in a beneficial way (reviewed in [44]). Finally, similar to
our findings, the IBS studies suggested a role for the Firmicutes
in the occurrence of the intestinal symptoms [39,40]. However,
the correlating taxa in the IBS patients (Lactobacilli, Veillonella
spp. and an uncharacterized Ruminococcus) [39,40] were mostly
distinct from ours that were dominated by uncultured and
uncharacterized members of Clostridiaceae, Ruminococcaceae and
Lachospiraceae.
This study addressed conceptually as well as concretely the
common core microbiota, which may comprise of the taxa that
have been selected during the mutual co-evolution of man and his
GI microbiota as beneficial partners. Once catalogued, the
functional characterization can be focused on these salient
microbiota members that possess potential even for therapeutic
applications if they are validated to benefit human health and well-
being. Our novel approach focusing on the conceptual rather than
concrete definition of the common core microbiota show that the
core size is highly conditional, depending both on the depth of the
analysis and the selected prevalence of the desired phylotypes. The
deterministic impact of the coverage of analysis on the common
core is supported by the previous finding where doubling the
sequencing depth increased the amount of shared species by 25%
[8].
By including all the phylotypes above the specified detection
limit, we found out that over 40% of the phylotypes were shared
among all the nine healthy subjects. The previous sequencing-
derived estimates of the share of the shared bacteria have ranged
from 0–2% [12,24] to over 30% [8,26]. We hypothetize that our
large core arises from technical aspects that supported the
detection of the shared bacteria as efficient extraction of the
community DNA [29] was coupled to its in-depth compositional
analysis, covering phylotypes with notably low relative abundance
(below 0.05%). Such rare taxa are not accessible with conventional
sequencing depth [8,25] and therefore have often remained
undetected. Moreover, our core estimate is arguably less random
than the previous ones as it was limited to the previously identified
phylotypes due to the microarray technology, and rested upon
multiple samples per individual. Hence, in contrast to earlier
assumption about the unambiguous dominance of the subject-
specific phylotypes in the GI microbiota [12,45], this study
supports a view that a large part of the intestinal bacteria is present
in most of the individuals, although in a highly uneven
proportions. If so, the individuality of the microbiota would be
attributable both to the differential ratios and the pure presence or
absence of particular lineages.
In the Finnish subjects analyzed in this study the common core
microbiota consisted mainly of uncultured Firmicutes from the
Clostridium clusters IV and XIVa, which are also highly
represented in the earlier core studies [13,24,27]. As a novel
observation we found hybridization signal identifying Oxalibacter-
ium formigenes, a betaproteobacterium within order Burkholderiales,
among the putative core bacteria (Figures 5B and 5C, Table S5).
An unclassified Burkholderiales was recently detected as part of
the healthy core [26]. O. formigenes is one of the few colonic bacteria
with well-defined health benefit as it is controls the oxalic acid
homeostasis and prevents the formation of kidney stones [46,47].
Uncharacterized Firmicutes affiliated to the same or related
genera that dominated our common core (Faecalibacterium,
Oscillospira, Subdoligranulum) were recently reported as ‘‘healthy
specific’’ as their abundance and/or prevalence was discriminative
between Crohn’s disease patients and healthy controls [48]. In
contrast, Bacteroidetes spp. were not an abundant part of the
common core microbiota. The previous studies either support
[12,24,27] or contradict [8,14,26] our finding about the low
representation of the Bacteroidetes in the common core. While
some differences may be attributable to the methodological
variation between the studies, our finding of the low proportion
of Bacteroidetes (4.5%) in the common core is in line with their
high inter- and intra-individual variation [15,24,35].
Core Microbiota and Digestive Symptoms in Adults
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e23035
The core phylotypes were temporally more stable than the total
pool of the phylotypes, similarly to another recent study [27]. The
fact that the stable phylotypes varied among the subjects and only
few genus-level taxa were stabile in majority of the healthy subjects
(Table S1) support the paradigm of functional redundancy of the
GI microbiota, according to which the key processes can be
carried out by several taxa. The vast majority of our most stabile
genus-level taxa belonged to Clostridial clusters IV and XIVa that
contains most of the butyrate producers, testifying for the assured
production of this essential metabolite that contributes to the
mutualistic homeostasis between the host and the GI microbiota
(reviewed in [49]). In our cohort Bifidobacteria were not included
in the common core, instead we detected substantial inter- and
intra-individual variation that was associated to occurrence of
abdominal pain and other intestinal symptoms. Bifidobacteria
were in some subjects among the enriched unstable genus-level
taxa (Table S2), which is in line with certain previous results [50]
but contradicts to many earlier studies, which have reported high
temporal stability of this genus [11,51,52]. In summary, our
findings emphasize the role of Bifidobacteria in the GI ecosystem
and warrant their further analysis as regards to the intestinal
health. These studies are expected to elucidate also the arisen
disparity regarding their intra-individual stability.
Unlike any other genus-level taxon, the temporal stability of the
F. prausnitzii group depended on its abundance in the given host.
Although F. prausnitzii et rel. was abundant in all the individuals
(Fig. 5C), it was temporally less stabile in those individuals that had
the lowest signal intensity. Our finding may simply reflect situation
where F. prausnitzii et rel. populations were transiently imbalanced
i.e. either declining or re-establishing for a reason or another. F.
prausnitzii has appeared as a health-associated and colitis-reducing
bacterium [2,48,53]. Among healthy individuals we did not find
evidence for the anticipated negative association between F.
prausnitzii et rel. and the intestinal symptoms. As the genus
Faecalibacterium appears functionally more diverse than previously
thought [54], its further characterization is required to identify the
phylotypes and metabolic features that are essential for the
intestinal and general health.
In conclusion, this work extends and defines our current
understanding about the normal GI microbiota in healthy subjects
by addressing its temporal dynamics, relation to intestinal
symptoms and the common core. This knowledge will bring us
closer to the definition of intestinal health and the contribution of
the GI microbiota within.
Methods
Subjects and study design
The study subjects (Table 1) were a subset of healthy Finnish
adults (n = 15) from a larger randomized, double-blind, placebo-
controlled nine-week intervention trial (Kekkonen et al., unpub-
lished results). Before entering the study, the subjects gave their
written informed consent. The study protocol was approved by
the Ethics Committee of the Hospital District of Helsinki and
Uusimaa (Ethical protocol HUS 357/E0/05). Exclusion criteria
were chronic illnesses, gastrointestinal diseases and related
medications, use of antibiotics or acute gastrointestinal disorders
during the two months before the study, pregnancy, and
lactation. The trial consisted of run-in, intervention and follow-
up periods, each three week. Fecal samples were collected at six
timepoints during seven weeks (at weeks 2,3,4,6,7,9), resulting in
a total of 88 samples after two dropouts. During the intervention
period the subjects received study drink containing either
bacterial strains frequently used in dairy fermentation, namely
Streptococcus thermophilus THS (n = 4), Lactococcus lactis ATH74
(n = 2), Leuconostoc mesenteroides PIA2 (n = 7), or placebo (n = 2).
As the recruitment to this sub-study occurred after randomization
in the mother study, we could not affect the number of subjects
per intervention group. The subjects were not allowed to
consume any probiotics or fermented dairy products during the
trial and hence had a restricted exposure to the dietary microbes.
Before the data analysis, we tested the possible effect of the
intervention on the microbiota. No statistically significant
difference between the intervention groups were observed with
the analysis of variance (ANOVA) that was applied to the
phylotype-level data above the specified threshold (log10 value of
1.8; see below). However, when also the phylotypes below the
detection threshold were included, a single statistically significant
(q,0.005) difference was observed: The Leuconostoc-like phylo-
types transiently increased during the intervention in the group
consuming L. mesenteroides PIA2. While the result testified for
the high resolution of the HITChip analysis, we only addressed the
signals above the background in the present analysis, and thus the
subjects were considered to constitute a uniform group in terms of
the microbiota composition.
At the time of each fecal sampling the subjects filled a Health-
Related Quality of Life (HRQoL) -questionnaire, which was based
on the RAND-36 questionnaire [55] and was supplemented with
questions assessing the GI symptoms as adapted from the Irritable
Bowel Syndrome Questionnaire [56]. The questions covered
general and emotional health with focus on the intestinal
symptoms whose occurrence and impact on daily activities were
assessed with 14 questions (listed in Figure 3) using 5-step Likert
scale (e.g. 1 = no symptom, 5= very severe disturbance). The
recall period was one or two weeks according to the sampling
intervals. The health scores were obtained by scoring each
question from 0 to 100 and then averaging related questions to
form the general, intestinal and emotional health score. In
addition, the participants provided data that covered possible
illness, medication and travelling abroad during the study.
Fecal samples and DNA extraction
The fecal samples we collected at home, immediately frozen at
220uC, and transported within 12 hours to the study center where
they were stored at 270uC until analyses. Community DNA was
extracted from the fecal samples with a repeated bead beating
method that has been recently validated [29]. The extracted DNA
was quantified with a Nanodrop spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA) and analyzed by 0.8%
agarose gel electrophoresis for integrity.
Microarray analysis
The HITChip microarray analyses were performed as previ-
ously described [13]. In brief, the HITChip consists of over 4 800
oligonucleotide probes targeting the V1 and V6 hypervariable
regions of the 16S rRNA gene, spotted in duplo on the custom
Agilent arrays (Agilent Technologies, Palo Alto, CA, USA). To
prepare the fecal DNAs for the microarray analysis, full-length 16S
rRNA gene was amplified using primers T7prom-Bact-27-for and
Uni-1492-rev [13]. The PCR products were transcribed into RNA
and labeled with Cy3 and Cy5 prior to fragmentation and
hybridization on the array. The arrays were scanned with Agilent
DNA Microarray Scanner and the data were extracted from the
generated images using the Agilent Extraction Software 9.1.
Computational pre-processing of the microarrays
The array normalization was conducted as described earlier
[13,29] including spatial normalization with polynomial regression
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of the each scanner channel followed by outlier detection and
quantile normalization of both of the Cy3 and Cy5 dyes for each
sample. The duplicates that showed over 0.98 Pearson correlations
between the dyes were considered for further analysis and the dyes
were averaged, otherwise the hybridization was reproduced. The
between-array normalization of the samples was conducted by
using the assumption of normal-exponential (background-signal)
distribution and quantile normalization [57]. The array probes
were organized based on their 16S rRNA sequences on three
levels of phylogeny as described before [13]. In brief, the HITChip
signal intensity was analyzed using the following phylogenetic
assignment levels: 1) the phylum-level, with the specification of
Firmicutes down to Clostridium clusters, creating altogether 23
groups; 2) the genus-like level, including 131 groups of sequences
with $90% sequence identity, and 3) the phylotype (species-like)
level with 1033 distinct phylotypes with $98% sequence similarity
to cultured species or clones corresponding to uncultured micro-
organisms. ‘‘Genus-level taxa with $90% sequence identity
distributed over multiple genera are termed ‘‘et rel. ’’. To reduce
the experimental and potential cross-hybridization noise, and to
reliably assess whether certain phylotypes were present in a sample
based on the hybridization intensity distributions of all the
subjects, we estimated the signal intensity threshold from the data
using the approach originally developed for gene expression
microarrays [58]. The thus obtained signal intensity threshold was
log10 intensity of 1.8 (Figure S1), corresponding to estimated
0.02% of the total signal as a detection limit for each phylotype.
To increase the analysis reliability, we additionally determined the
probe specificities for each phylotype by calculating the number of
the targeted phylotypes per probe in order to specify taxa that are
potentially subject to cross-hybridization (i.e. are detected with
probes that have more than one target phylotype based on the
hypervariable V1 and V6 sequences of the 16S rDNA). Multiple
targeted phylotypes were essentially detected only within the same
genus-level taxa. Additionally, the Robust Probabilistic Averaging
algorithm was used to estimate the reliability of the individual
HITChip probes in regard to noise attributable e.g. to unintended
cross-hybridization with non-target sequences [34], potentially
resulting in false positives in the common core analysis. Previously,
a good correlation between the HITChip- and pyrosequencing-
derived microbial profiles has been recorded [30,59].
Quantitative PCR analysis
Triplicate quantitative PCR (qPCR) amplifications of the 16S
rRNA gene were performed for all available samples using the
MX3005P Real-Time PCR System (Stratagene, La Jolla, CA,
USA) and CYBR green chemistry. Total bacteria were quantified
by amplifying 0.5 ng of fecal DNA with universal primers [60].
The archaea were quantified using primers specific for the genus
Methanobrevibacter [61] and 25 ng of the template DNA. The assays
for Faecalibacterium prausnitzii and Bifidobacterium spp. were conduct-
ed as described previously [62]. The reaction conditions and
construction of standard curves have been previously described
[29,62]. The data are expressed as 16S rRNA gene copies mg-1
template DNA.
Data analyses
The data analyses were performed in R version 2.10.1 [63] and
Microsoft Excel. The statistical analysis methods used in this study
included linear models with ANOVA (for intervention effects) and
t-tests [64,65] for normally distributed data, Wilcoxon [66] test for
non-normal data, determination of false discovery rate of p-values
as q-values [67] and statistical over-representation (enrichment) of
genus-level groups in phylotypes-level lists using Fisher’s exact test
[68]. We visualized the data by using hierarchical clustering and
heatmap analyses. The hierarchical clustering was used to group
the samples according to the correlation distance and average
clustering criterion.
All data analyses were conducted with log-transformed data,
with exception of the estimation of the percentual abundances
from the total signal and calculation of the signal fold changes in
relation to bloating and abdominal pain. We determined the
microbial stability by calculating the intra- and inter-individual
Pearson correlations (r), and the temporal variation of the
individual phylotypes by calculating the Coefficient of Variation
(CoV) within a subject from all timepoints. Mean standard
deviation was calculated for the correlations and expressed in the
text as 6.
To analyze the significant correlations between the microbial
profiles and the intestinal symptoms in the HRQoL-questionnaire
we calculated their Spearman’s rank correlation coefficient (r). All
HRQoL items are scored so that a high score indicates a good
health status (22), which resulted in non-intuitive direction of
correlations i.e. in negative correlation upon simultaneous increase
of the bacterial abundance and symptom severity due to the drop
of the HRQoL score. Hence, to truthfully express the association
between the symptoms and the microbiota data, the direction of
resultant correlations (r) was inversed from negative to positive
and vice versa. Using the HRQoL GI symptom scores, we divided
the samples into two groups: with and without concurrent
abdominal pain and bloating, and then used these groups to
analyse the association between microbiota composition and the
two most commonly recorded intestinal symptoms. We analyzed
the common core microbiota with the phylotype-level data using
adjustable parameters for the abundance (relative contribution to
the total signal) and prevalence (number of affected subjects). The
resulting surface was visualized with a perspective plot [69]. For all
analyses, p-values below 0.05 and q-values below 0.005 were
considered significant.
Supporting Information
Figure S1 HITChip signal intensity distribution of all
phylotypes in the entire data set (15 subjects, 88
samples). The red line indicates the threshold of log10 intensity
.1.8, above which any phylotype was considered to be present.
Altogether 687 phylotypes passed the treshold, representing 66.5%
of the phylotypes detectable with the HITChip.
(TIF)
Figure S2 Effect of travelling on the microbiota stabil-
ity. Similarity of the HITChip fingerprints between two
consecutive timepoints of each traveller is expressed using Pearson
correlation.
(TIF)
Figure S3 Temporal variation of the core phylotypes.
The line indicates Coefficient of Variation (CoV) of the common
core phylotypes. The phylotypes with less than 10% variation
within the seven week study period are summed up to phylum
level.
(TIF)
Figure S4 Correlation between temporal stability and
abundance. Vertical lines indicate absence of correlation
between the temporal stability (CoV) and abundance (%) for the
genus-level taxa specified in the box. In the case of F. Prausnitzii
group, the line connects high values on both axes and visualizes
the negative correlation between the two parameters.
(TIF)
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Table S1 Statistically enriched stable genus-like taxa
from nine healthy subjects.
(DOCX)
Table S2 Statistically enriched unstable genus-like taxa
from nine healthy subjects.
(DOCX)
Table S3 List of phylotypes correlating significantly
with bloating.
(DOCX)
Table S4 List of phylotypes correlating significantly
with abdominal pain.
(DOCX)
Table S5 Phylotypes in the common core microbiota;
shared between nine healthy subjects and contributing
over 0.03% to the total signal intensity.
(DOCX)
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